Critical Outcome Technologies Inc. Share Price Other OTC
Equities
CA22675B1031
Biotechnology & Medical Research
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 135M |
---|---|---|---|---|---|
Net income 2018 | -4M -334M | Net income 2019 | -2M -167M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 3.4M | Net cash position 2019 | 24.64K 2.06M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01/15/01 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12/17/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/18/01 | |
John C. Drake
CHM | Chairman | - | 20/07/20 |
Alison D. Silva
PSD | President | 46 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+3.67% | 108B | |
+11.10% | 104B | |
+1.28% | 22.33B | |
-12.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.60% | 17.64B | |
+3.77% | 14.05B | |
+36.90% | 12.51B |